Ideal candidates include adults with type 2 diabetes, particularly those with obesity, cardiovascular disease, or inadequate control on other agents
However, certain elements, such as existing CVDs or CKD, could affect how GLP-1 responds
Are tirzepatide and semaglutide both FDA-approved
Some people also experience diarrhoea or more frequent bowel movements, although the precise mechanism by which GLP-1 receptor agonists cause diarrhoea is not fully understood and is likely to involve multiple factors
Combined with personalized guidance from the Fit Body Weight Loss team, it may help support appetite control, healthy metabolism, and long-term weight management as part of a comprehensive wellness program
doi:10.1161/CIRCULATIONAHA.121.056015 Schjerning AM, McGettigan P, Gislason G